Vimarsana
Biggest News Aggregation in the World

Page 3 - Injectable Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Injectable Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Injectable Solutions Today - Breaking & Trending Today

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection - Vimarsana News

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping posaconazole injection (18...

Endo International plc: Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant® - Vimarsana News

Endo International plc: Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

DUBLIN, June 15, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping dexlansoprazole 30

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant® - Vimarsana News

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping...

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe - Vimarsana News

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe

The ready-to-use pre-filled syringe combines two well-known, FDA-approved products in a standard concentration ratio Product eliminates the need for two discrete syringe preparations and... | June 12, 2023

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials - Vimarsana News

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that its subsidiary Endo Ventures Limited has executed an agreement with MAIA...